Crossmark Global Holdings’s US Physical Therapy USPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-74,428
Closed -$8.69M 1317
2023
Q2
$8.69M Buy
74,428
+433
+0.6% +$46.7K 0.19% 143
2023
Q1
$7.24M Buy
73,995
+2,152
+3% +$205K 0.17% 154
2022
Q4
$5.82M Buy
71,843
+2,762
+4% +$232K 0.15% 180
2022
Q3
$5.25M Buy
+69,081
New +$6.64M 0.15% 170
2018
Q4
Sell
-2,633
Closed -$312K 1555
2018
Q3
$312K Sell
2,633
-360
-12% -$40.7K 0.01% 1285
2018
Q2
$287K Buy
2,993
+330
+12% +$30.6K 0.01% 1330
2018
Q1
$217K Sell
2,663
-463
-15% -$35.9K 0.01% 1458
2017
Q4
$226K Sell
3,126
-1,327
-30% -$90.5K 0.01% 1527
2017
Q3
$274K Buy
+4,453
New +$271K 0.01% 1374
2016
Q3
$274K Buy
+4,453
New +$275K 0.01% 1374

Other funds holding USPH

Crossmark Global Holdings's USPH Position: Q3 2023 in Review

Crossmark Global Holdings sold out of US Physical Therapy (USPH) in Q3 2023, closing a stake of 74,428 shares — an estimated $8.69M sold.

Crossmark Global Holdings first reported a position in USPH in Q3 2016 and held it in 10 quarters. The position peaked at $8.69M in Q2 2023. 217 funds tracked by Wall St. Rank hold USPH as of Q3 2023.

  • Crossmark Global Holdings reported no remaining US Physical Therapy position as of Q3 2023 after selling out during the quarter.
  • Crossmark Global Holdings sold 74,428 US Physical Therapy shares in Q3 2023, an estimated $8.69M.
  • Crossmark Global Holdings first reported a position in US Physical Therapy in Q3 2016 and held it in 10 quarters.
  • Crossmark Global Holdings's US Physical Therapy position peaked at $8.69M in Q2 2023.
  • 217 funds tracked by Wall St. Rank held US Physical Therapy as of Q3 2023.

Based on Crossmark Global Holdings's 13F filing for Q3 2023, filed 8 Nov 2023.